Interstitial lung disease (ILD)
Conditions
Interventions
low dose group:1×10^6/kg cells
high dose group:2×10^6/kg cells
Sponsors
Shanghai Sixth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with imaging findings consistent with ILD; 2. Aged >18 years and <=80 years, no gender limit; 3. Good compliance, healthy mental state, able to cooperate with research and observation; 4. No complications (acute infection, heart failure, hepatitis, nephritis); 5. Fully informed of the purpose, methods and possible discomfort of the study, agreed to participate in the study, and signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients who cannot tolerate cell therapy; 2. Participate in other drug trials 3 months before enrollment; 3. Pregnant or lactating patients or those who have a recent birth plan and cannot take effective contraceptive measures; 4. If there is anything that the researcher considers inappropriate for inclusion.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| high resolution computed tomography (CT)T;treatment endpoint events; | — |
Primary
| Measure | Time frame |
|---|---|
| lung function;6 minutes walk test;St George's score; | — |
Countries
China
Contacts
Public ContactRen Tao
Shanghai Sixth People's Hospital
Outcome results
None listed